BRIEF-Bioline says filed regulatory submissions to start Phase 2A trial for BL-8040
 

BRIEF-Bioline says filed regulatory submissions to start Phase 2A trial for BL-8040
* Filed regulatory submissions required to commence phase 2atrial for bl-8040 in combination with keytruda in patients withpancreatic cancerhttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...v8:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...v8:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/0746DqMA3gA